`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`GALDERMA S.A. &
`Q-MED AB
`Petitioner
`
`v.
`
`ALLERGAN INDUSTRIE, SAS
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2014-01422
`Patent 8,357,795
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER ALLERGAN INDUSTRIE SAS’S
`MANDATORY NOTICES
`
`
`
`Case IPR2014-01422
`Attorney Docket No: 13351-0030IP1
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, Allergan Industrie, SAS
`
`(“Patent Owner”), hereby submits the following Mandatory Notices in response to
`
`the Petition for Inter Partes Review of U.S. Patent No. 8,357,795.
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`Each of Allergan Industrie, SAS; Allergan USA, Inc.; Allergan Sales, LLC;
`
`Allergan Holdings France SAS; Allergan Holdings Limited; Allergan Holdings,
`
`Inc.; Allergan Puerto Rico Holdings, Inc.; and Allergan, Inc. is a real party-in-
`
`interest in this proceeding.
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding: Allergan USA, Inc. et al. v. Medicis Aesthetics, Inc.,
`
`et al., Case No. SACV 13-1436 AG (JPRx) (C.D. Cal.).
`
`Patent Owner has filed the following continuation applications that claim
`
`priority to U.S. Patent No. 8,357,795: 14/170,310 filed on 01-31-2014 which is
`
`pending; 14/242,747 filed on 04-01-2014 which is pending; 14/242,752 filed on
`
`04-01-2014 which is pending; 13/653,251 filed on 10-16-2012 which is pending;
`
`13/653,266 filed on 10-16-2012 which is pending; 13/746,170 filed on 01-21-2013
`
`which is pending.
`
`2
`
`
`
`Case IPR2014-01422
`Attorney Docket No: 13351-0030IP1
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`3.
`
`The Patent Owner designates the following lead and back-up counsel:
`
`LEAD COUNSEL
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email:
`dpw@fr.com
`Fax:
`
`(612) 288-9696
`
`BACK-UP COUNSEL
`J. Patrick Finn III, Ph.D, Reg. No. 44,109
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2554
`Email: IPR13351-0030IP1@fr.com
`Fax:
` (612) 288-9696
`
`Michael Kane, Reg. No. 39,722
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2502
`Email: IPR13351-0030IP1@fr.com
`Fax:
` (612) 288-9696
`
`
`4.
`
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`Please address all correspondence and service to both counsel as listed
`
`above. Patent Owner consents to service by email at IPR13351-0030IP1@fr.com
`
`(ref.: Docket No. 13351-0030IP1).
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`
`
`
`3
`
`
`
`
`
`Date:/September 18, 2014/
`
`
`Customer Number 26191
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`
`
`Case IPR2014-01422
`Attorney Docket No: 13351-0030IP1
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on September 18, 2014, a complete and entire copy of this Patent Owner
`
`Allergan Industrie, SAS’s Mandatory Notices and Power of Attorney were
`
`provided via electronic service, to the Petitioner by serving the correspondence
`
`address of record as follows:
`
`Weihong Hsing, ph.D.
`Panitch Schwarze Belisario & Nadel LLP
`2005 Market Street, Suite 2200
`Philadelphia, PA 19103-7013
`
`uspto@panitchlaw.com
`whsing@panitchlaw.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /Susan C. Johnson
`Susan C. Johnson
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(214) 292-4086
`
`4